# Cost-Effectiveness Evaluation of Oral CGRP Antagonists, Atogepant and Rimegepant, for the Preventative Treatment of Episodic Migraine: Results from a US Societal Perspective Model

> Research article (Clinical Drug Investigation, 2024) · cited 11× · AI/ML

**Wikidata**: [openalex:W4391996366](https://www.wikidata.org/wiki/openalex:W4391996366)  
**Source**: https://4ort.xyz/entity/cost-effectiveness-evaluation-of-oral-cgrp-antagonists-atogepant-and-rimegepant-for-the-preventative-treatment-of-episod